Answers are grounded in this paper and cite their sources.
The growth of solid tumors is certainly angiogenesis dependent. However, the role of angiogenesis in the growth and survival of leukemias and other hematological malignancies has only been rendered evident since 1994 in a series of demonstrations showing that the progression of several forms is clearly related to their degree of angiogenesis. Here, we present an overview of the literature concerning the relationship between angiogenesis and disease progression in several hematological malignancies and the recent advances in antiangiogenesis in these diseases and we describe the most important active substances, preclinical and clinical data, and future perspectives.
No takes yet. Share an insight, caveat, or question.
Ribatti et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: